These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 28349992)

  • 1. Central Neuromodulators for Treating Functional GI Disorders: A Primer.
    Sobin WH; Heinrich TW; Drossman DA
    Am J Gastroenterol; 2017 May; 112(5):693-702. PubMed ID: 28349992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirically Supported Use of Psychiatric Medications in Adolescents and Adults with IBD.
    Thorkelson G; Bielefeldt K; Szigethy E
    Inflamm Bowel Dis; 2016 Jun; 22(6):1509-22. PubMed ID: 27167571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuromodulators for Functional Gastrointestinal Disorders (Disorders of Gut-Brain Interaction): A Rome Foundation Working Team Report.
    Drossman DA; Tack J; Ford AC; Szigethy E; Törnblom H; Van Oudenhove L
    Gastroenterology; 2018 Mar; 154(4):1140-1171.e1. PubMed ID: 29274869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central Neuromodulators in Irritable Bowel Syndrome: Why, How, and When.
    Hanna-Jairala I; Drossman DA
    Am J Gastroenterol; 2024 Jul; 119(7):1272-1284. PubMed ID: 38595149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychopharmacology of chronic pain: a focus on antidepressants and atypical antipsychotics.
    Khouzam HR
    Postgrad Med; 2016; 128(3):323-30. PubMed ID: 26821680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of Functional Abdominal Pain With Antidepressants: Benefits, Adverse Effects, and the Gastroenterologist's Role.
    Zar-Kessler CAM; Belkind-Gerson J; Bender S; Kuo BM
    J Pediatr Gastroenterol Nutr; 2017 Jul; 65(1):16-21. PubMed ID: 28644344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic review and meta-analysis: Dose-response curve of SSRIs and SNRIs in anxiety disorders.
    Jakubovski E; Johnson JA; Nasir M; Müller-Vahl K; Bloch MH
    Depress Anxiety; 2019 Mar; 36(3):198-212. PubMed ID: 30479005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pain Relief in Depressive Disorders: A Meta-Analysis of the Effects of Antidepressants.
    Gebhardt S; Heinzel-Gutenbrunner M; König U
    J Clin Psychopharmacol; 2016 Dec; 36(6):658-668. PubMed ID: 27753729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates of 5 common antidepressant side effects among new adult and adolescent cases of depression: a retrospective US claims study.
    Anderson HD; Pace WD; Libby AM; West DR; Valuck RJ
    Clin Ther; 2012 Jan; 34(1):113-23. PubMed ID: 22177545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological interventions for somatoform disorders in adults.
    Kleinstäuber M; Witthöft M; Steffanowski A; van Marwijk H; Hiller W; Lambert MJ
    Cochrane Database Syst Rev; 2014 Nov; 2014(11):CD010628. PubMed ID: 25379990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tricyclic antidepressants for preventing migraine in adults.
    Xu XM; Liu Y; Dong MX; Zou DZ; Wei YD
    Medicine (Baltimore); 2017 Jun; 96(22):e6989. PubMed ID: 28562550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translating the evidence on atypical depression into clinical practice.
    Rapaport MH; Thase ME
    J Clin Psychiatry; 2007 Apr; 68(4):e11. PubMed ID: 17474801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
    Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
    Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of neurotransmitter regulators in functional gastrointestinal disorders based on symptom analysis.
    Luo QQ; Chen SL
    J Dig Dis; 2017 Apr; 18(4):203-206. PubMed ID: 28371414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidepressants for functional gastrointestinal disorders in children.
    Tan E; Smith CH; Goldman RD
    Can Fam Physician; 2013 Mar; 59(3):263-4. PubMed ID: 23486795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remission, dropouts, and adverse drug reaction rates in major depressive disorder: a meta-analysis of head-to-head trials.
    Machado M; Iskedjian M; Ruiz I; Einarson TR
    Curr Med Res Opin; 2006 Sep; 22(9):1825-37. PubMed ID: 16968586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personalized medicine in functional gastrointestinal disorders: Understanding pathogenesis to increase diagnostic and treatment efficacy.
    Wang XJ; Camilleri M
    World J Gastroenterol; 2019 Mar; 25(10):1185-1196. PubMed ID: 30886502
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensory neuromodulators in functional nausea and vomiting: predictors of response.
    Patel A; Sayuk GS; Kushnir VM; Gyawali CP
    Postgrad Med J; 2013 Mar; 89(1049):131-6. PubMed ID: 23112216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
    Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
    Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment considerations for patients with neuropathic pain and other medical comorbidities.
    Haanpää ML; Gourlay GK; Kent JL; Miaskowski C; Raja SN; Schmader KE; Wells CD
    Mayo Clin Proc; 2010 Mar; 85(3 Suppl):S15-25. PubMed ID: 20194144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.